南戈壁-S(01878.HK):不列顛哥倫比亞證券委員會發出停止交易令
格隆匯6月21日丨南戈壁-S(01878.HK)公佈,不列顛哥倫比亞證券委員會於温哥華時間2020年6月19日向公司發出一般未能申報停止交易令(CTO),禁止任何人士於加拿大買賣本公司的任何證券。公司的普通股交易因CTO的生效於多倫多證劵交易所暫停買賣。
發出CTO是由於公司無法於2020年6月15日前提交2019年年度申報及2020年中期申報。CTO將維持生效,直至公司提交2019年年度申報及2020年中期申報時為止。公司無法保證將能夠補救其違反申報的情況並及時或完全解除CTO。公司股東對公司普通股的投資可能會遭受重大損失或全部損失。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.